Board Membership, Creighton University, Health ans Safety
Assistant Professor
After earning a Masters of Pharmacy from Pune University (India) in 1998, Dr. Gopal worked as a synthetic chemist for a year and taught medicinal chemistry for three years before beginning a PhD at the University of Nottingham (UK). In the five years after his Ph.D., he worked as a post-doctoral research fellow on three projects: one on cancer research, financed by the BBSRC in the UK; another on drug discovery, funded by the Wellcome Trust; and one on osteoporosis, funded by the MRC in the UK. After that, Dr. Jadhav worked for about two years as a senior research scientist at GlaxoSmithKline's RD Alternative Discovery & Development (Madrid Trescants, Spain) on a collaborative project that involved structural optimization of the hPDE4 inhibitor GSK675728A to produce novel pharmacophore(s) as potent TbrPDE1 inhibitors that are selective over hPDEs in the management of African sleeping sickness (CNS disorder). Dr. Gopal started working as a postdoctoral researcher at Creighton University in June 2016 and was later promoted to assistant professor of medicinal chemistry in early 2017. He is presently tenure track faculty in the school of medicine working under Dr. Peter Abel.
Lab Research Focus: Dr. Jadhav’s Lab is aimed at; A) Molecular docking and Structure Activity Relationship (SAR) based small molecular drug discovery to tackle biological problems such as Neuroinfllamatory disorders, Cancers, Noise induced hearing loss (NIHL) and Antibiotic resistant Bacterial infections. Current projects involve (1) Development of Triggering receptors expressed on myeloid cells-1 (TREM1) inhibitors to treat neuronal disorders, NIHL and liver cancer. (2) Development of small molecules as Mvfr inhibitors to treat antibiotic resistant Pseudomonas aeruginosa infections. B) PROTAC (Proteolysis targeting chimeras) therapeutics: to address liver cancer and Neuroinflmmations. C) Dual conjugates of Latanoprost acid to release Nitrous oxide (NO) and Hydrogen suflide (H2S) in the management of gloucoma. D) Hybrid analogs in the management of Alzheimer’s disease
Synthetic organic chemistry: Hands on experience in modern synthetic organic chemistry like multi-step syntheses of drug like molecules, heterocycles, peptides, etc., parallel synthesis using Radley’s. Independent planning and execution of SAR.
Research Focus
Drug discovery in Cardiac and cardiovascular disorders Drug discovery in immuno and inflammatory disorders Drug discovery in Quorum sensing Drug discovery in Highly neglected diseases
Laser Therapies : Types, Uses and Safety Hati Santanu, Jadhav Gopal P., Laser technology to facilitate drug discovery and development processes [Book Chapter] 2020
General
Jadhav Gopal P., Prathipati Pavan Kumar, Chauhan Harsh, Surface plasmon resonance, Orbitrap mass spectrometry and Raman advancements 2020
Publications
International journal of molecular sciences Trivedi Neerja, Bhosale Jitendra D., Pant Amit, Suryawanshi Sonali P., Tiwari Prerna, Abel Peter W., Jadhav Gopal P., Triggering Receptor Expressed on Myeloid Cells-1 (TREM-1) in Inflammation and Disease: Mechanisms, Therapeutic Potential, and Future Directions 26:21, p. 10386 2025
International journal of molecular sciences Boosani Chandra S., Subramanyam Pradeep N., Jadhav Gopal P., Hybrid Receptor-Mediated Molecular Delineations in TNF-α and IGF-1-Induced Costimulatory Effects 26:20, p. 10027 2025
Current Indian Science Bhosale Jitendra D., Bendre Ratnamala S., Jadhav Gopal, Dabur Rajesh, An Overview of the Synthesis of 3,4 -Dimethyl- 1H -Pyrrole and its Potential Applications 3 2025
Molecules (Basel, Switzerland) Kaur Ishwinder, Jadhav Gopal P., Fischer Peter M., Winkler Gerlof Sebastiaan, The Discovery of Substituted 5-(2-Hydroxybenzoyl)-2-Pyridone Analogues as Inhibitors of the Human Caf1/CNOT7 Ribonuclease 29:18, p. 4351 2024
BULLETIN OF THE UNIVERSITY OF KARAGANDA-CHEMISTRY Bhimanwar R., Thomas A., Kothapalli L., Godase A., Gandhi S., Chandani S., More G., Jadhav G., Choudhary S., Prospective Hybrid Molecules with Dual Anti-Viral and Anti-Thrombotic Activity Against the SARS-CoV-2 Infection and Its Associated Complications Employing in Silico Studies, p. 76 - 88 2022
FEBS Open Bio Airhihen Blessing, Jadhav Gopal P., Fischer Peter M., Winkler Gerlof Sebastiaan, Pavanello Lorenzo, 1-Hydroxy-xanthine derivatives inhibit the human Caf1 nuclease and Caf1-containing nuclease complexes via Mg 2+ -dependent binding 9:4, p. 717 - 727 2019
Journal of Cardiovascular Development and Disease Kouassi Kouassi T., Gunasekar Palanikumar, Agrawal Devendra K., Jadhav Gopal P., TREM-1; Is it a pivotal target for cardiovascular diseases? 5:3 2018
Molecules Bhosale Jitendra D., Dabur Rajesh, Jadhav Gopal P., Bendre R. S., FacIle syntheses and molecular-docking of novel substituted 3,4-dimethyl-1H-pyrrole-2-carboxamide/ carbohydrazide Analogues with antimicrobial and antifungal properties 23:4 2018
FASEB Journal Baker Jillian G., Gardiner Sheila M., Woolard Jeanette, Fromont Christophe, Jadhav Gopal P., Mistry Shailesh N., Thompson Kevin S.J., Kellam Barrie, Hill Stephen J., Fischer Peter M., Novel selective β1-adrenoceptor antagonists for concomitant cardiovascular and respiratory disease 31:7, p. 3150 - 3166 2017
Bioorganic and Medicinal Chemistry Letters Jadhav Gopal P., Kaur Ishwinder, Maryati Maryati, Airhihen Blessing, Fischer Peter M., Winkler G. Sebastiaan, Discovery, synthesis and biochemical profiling of purine-2,6-dione derivatives as inhibitors of the human poly(A)-selective ribonuclease Caf1 25:19, p. 4219 - 4224 2015
Journal of Medicinal Chemistry Murray Ewan J., Cockayne Alan, Chhabra Siri Ram, Chan Weng C., Williams Paul, Crowley Rebecca C., Truman Alex, Clarke Simon R., Cottam James A., Jadhav Gopal P., Steele Victoria R., O'Shea Paul, Lindholm Catharina, Targeting Staphylococcus aureus quorum sensing with nonpeptidic small molecule inhibitors 57:6, p. 2813 - 2819 2014
Nucleic Acids Research Maryati Maryati, Kaur Ishwinder, Jadhav Gopal P., Olotu-Umoren Loyin, Oveh Blessing, Hashmi Lubna, Fischer Peter M., Winkler G. Sebastiaan, A fluorescence-based assay suitable for quantitative analysis of deadenylase enzyme activity 42:5, p. e30 2014
Journal of Medicinal Chemistry Jadhav Gopal P., Chhabra Siri Ram, Telford Gary, Hooi Doreen S.W., Righetti Karima, Williams Paul, Kellam Barrie, Pritchard David I., Fischer Peter M., Immunosuppressive but non-LasR-inducing analogues of the pseudomonas aeruginosa quorum-sensing molecule N-(3-Oxododecanoyl)-l-homoserine Lactone 54:9, p. 3348 - 3359 2011
Indian Drugs Jadhav Gopal P., Roy Tanya, Deshpande A. D., More H. N., Estimation of proxicam β-cyclodextrine from marketed formulations by RP-HPLC 36:8, p. 506 - 508 1999
Indian Drugs Kale A. D., Kachhwaha S. J., Jadhav G. P., Trivedi Piyush, Spectrophotometric estimation of dicyclomine hydrochloride from combined dosage forms by ion pair complex 35:11, p. 718 - 720 1998
Indian Drugs Jadhav Gopal P., More H. N., Mahadik K. R., Simultaneous estimation of nalidixic acid and metronidazole using uv/visible spectrophotometer 35:8, p. 475 - 480 1998
Indian Journal of Pharmaceutical Sciences Jadhav G. P., More H. N., Mahadik K. R., Simultaneous UV-spectrophotometric estimation of nalidixic acid and metronidazole from various multicomponent formulations 60:4, p. 246 - 248 1998
Presentations
Invited talk on " The development of selective Beta 1adrenergic receptor inhibitors for the management of Cardiovascular diseases".Venue: SGMSPM's Dnyanvilas College of Pharmacy, Pune, India.https://www.dvcop.com 2018
Invited talk on "TREM-1 drug discovery, a pivotal target for Cardiovascular disorders"Venue: STES's Sinhgad College of Pharmacy, Pune, India.www.sinhgad.edu 2018